##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 65 Download : 55

##plugins.themes.academic_pro.article.main##

Abstract

This article provides information about pneumonia and some related diseases, such as mycoplasma pneumonia. The article explains how early children experience these diseases and how to treat them. Also, the article provides detailed information about the measures that children and parents need to follow in order to avoid this disease

Keywords

pneumonia mycoplasma candidiasis infection

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Nabieva Zumrat Tukhtaevna. (2023). Mycoplasma Pneumonia in Young Children and Its Ways Of Treatment. Texas Journal of Medical Science, 27, 111–113. https://doi.org/10.62480/tjms.2023.vol27.pp111-113
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Al-Zaidy, S. A., MacGregor, D., Mahant, S., Richardson, S. E., and Bitnun, A. (2015). Neurological complications of PCR-proven M. pneumoniae infections in children: prodromal illness duration may reflect pathogenetic mechanism. Clin. Infect. Dis. 61, 1092–1098. doi: 10.1093/cid/civ473
  2. Ang, C. W., Tio-Gillen, A. P., Groen, J., Herbrink, P., Jacobs, B. C., Van Koningsveld, R., et al. (2002). Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome. J. Neuroimmunol. 130, 179–183. doi: 10.1016/S0165-5728(02)00209-6
  3. Atkinson, T. P. (2013). Is asthma an infectious disease? New evidence. Curr. Allergy Asthma Rep. 13, 702–709. doi: 10.1007/s11882-013-0390-8
  4. Averbuch, D., Hidalgo-Grass, C., Moses, A. E., Engelhard, D., and Nir-Paz, R. (2011). Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg. Infect. Dis. 17, 1079–1082. doi: 10.3201/eid/1706.101558
  5. Baer, G., Engelcke, G., Abele-Horn, M., Schaad, U. B., and Heininger, U. (2003). Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur. J. Clin. Microbiol. Infect. Dis. 22, 742–745. doi: 10.1007/s10096-003-1037-9
  6. "Pneumonia – Symptoms | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Retrieved 1 October 2022.
  7. ^ Jump up to:a b "Pneumonia – Causes and Risk Factors | NHLBI, NIH". www.nhlbi.nih.gov. 24 March 2022. Retrieved 1 October 2022.
  8. ^ Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J (July 2012). "Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis". BMJ. 345 (jul11 1): e4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934. Susceptibility is higher among elderly people (≥65 years)